Menu

Abundant Neurogenesis Found in Adult Humans’ Hippocampi

Researchers identified thousands of immature neurons in the brain region, countering a recent result showing little, if any, signs of neurogenesis.

Apr 5, 2018
Ashley Yeager

A comparison of stained neural progenitors (pink) in a young (left) and old (right) brainCOURTESY OF MAURA BOLDRINIAdult human hippocampi are home to thousands of immature neurons, researchers report today (April 5) in Cell Stem Cell. The result runs counter to a paper published last month in Nature that found no evidence of neural precursor cells or immature neurons in adults. Such contradictory findings raise questions about researchers’ understanding of neurogenesis in human adult hippocampi, which are central to learning and memory.

“There’s been a long-standing debate about adult human neurogenesis,” Xinyu Zhao, a neurobiologist at the University of Wisconsin-Madison who was not involved in either study, tells The Scientist. She says the latest work in Cell Stem Cell is notable because it uses stereology—the gold standard of neurogenesis studies in animals—to count immature and mature neurons in the hippocampi of healthy humans. Stereology can determine the number of individual cell types in tissue, even when the sample has been sliced into sections.

“I have never seen anybody do this in human tissue because availability of human tissue is a major problem,” Zhao says. “The fact they did this counting on the whole hippocampal tissue is remarkable.”

We dispute the interpretation of their cellular staining experiments as evidence of new neurons in the adult brain.—Mercedes Paredes and Shawn Sorrells,
University of California, San Francisco

In the new work, Maura Boldrini, a neurobiologist at Columbia University, and her colleagues examined postmortem brain tissue of 28 healthy people between 14 and 79 years old, less than 26 hours after the individuals had died. The team wanted to see if it could identify signs of neurogenesis in the human brain tissue given that past studies have reported mixed results about new neuron development in older human brains. To do this, the team quantified the abundance of specific proteins in hippocampal cells with marker antibody staining: GFAP, nestin, and Sox2 for neural progenitor cells; Ki-67 and nestin for intermediate neural progenitors; DCX and PSA-NCAM for immature granule neurons; and NeuN for mature granule neurons.

Many of these same markers were used to probe for different types of neuronal cells in the Nature study, but Baldrini notes that, in contrast to her material, some of the tissue used in that case wasn’t fixed until up to two days after death, and the researchers did not examine the whole hippocampus.

See “Study Finds No Neurogenesis in Adult Humans’ Hippocampi

Boldrini’s team found that in older adults the pool of neural progenitor cells was smaller in the front and middle of the dentate gyrus—the region of the hippocampus where neurogenesis is thought to occur—compared with younger adults. There were approximately 1,000 neural progenitor cells per front, middle, and back of the dentate gyrus in the older adults. However, intermediate neural progenitors did not appear to decline with age. There were thousands in each region from all the brains. Immature neurons were also present on the order of a few thousand per region of the dentate gyrus in each person, suggesting no decline in neurogenesis as people got older.

The researchers also found fewer PSA-NCAM+ cells of different morphologies in the front of the dentate gyrus from the brains of older people, which “likely represents a decline in neuroplasticity,” the team writes. If the cells weren’t migrating or sprouting dendrites—factors that change their morphology—it could mean they had trouble integrating into the already existing circuits, Boldrini explains. Older brains also had less development of new blood vessels compared with younger brains in the anterior dentate gyrus, the team found. The front region of the dentate gyrus, Boldrini explains, has been linked to emotion and is connected to amygdala, responsible for fear and stress. “This new result suggests that the anterior region might be more vulnerable to aging,” she says.

While the new study “offers interesting evidence of declining blood vessel growth in the adult hippocampus, we dispute the interpretation of their cellular staining experiments as evidence of new neurons in the adult brain,” Shawn Sorrells and Mercedes Paredes of the University of California, San Francisco (UCSF), coauthors of the Nature study, write in an email to The Scientist.

Sorrells and Paredes note that identifying new neurons in the hippocampus is technically challenging and that in their recent study, they made similar observations to Boldrini and her colleagues’, but after performing extensive additional analysis of the shape and appearance of the cells in question, including electron microscopy and gene expression, the UCSF researchers determined that the cells were not, in fact, young neurons or neural progenitors. They were different cell types altogether.

“Based on the numbers of putative young neurons indicated in this new study, we should have been able to detect these cells readily, if they were actually present. Therefore, the identity of the cells that were actually counted is questionable,” Sorrells and Paredes write. “For now, we do not think this new study challenges what we have concluded from our own recently published observations: If neurogenesis continues in the adult human hippocampus, it is an extremely rare phenomenon.”

Zhao isn’t so certain. Such staining, or histology, studies have limitations: protein levels, for example, can decrease if there is a long lag time, say, several days, between when a person died and when her tissue is fixed and analyzed. Different preparation protocols might lead to different results. “I would never consider this the only method to support neurogenesis or not,” she says. Zhao suggests researchers develop new methods to track neurogenesis in human adults.

M. Boldrini et al. “Human hippocampal neurogenesis persists throughout aging,” Cell Stem Cell, doi:10.1016/j.stem.2018.03.015, 2018.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.